BlackRock, Inc. (BLK) 13D/13G Filings for Evofem Biosciences, Inc. (EVFM)

BlackRock, Inc. 13D and 13G filings for Evofem Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-07-12
08:29 am
Sale		 2021-06-30 13G Evofem Biosciences, Inc.
EVFM		 BlackRock Inc.
BLK		 1,811
2.300%		 -970decrease
(-34.87%)		 Filing
2021-02-02
3:13 pm
Purchase		 2020-12-31 13G Evofem Biosciences, Inc.
EVFM		 BlackRock Inc.
BLK		 2,781
6.400%		 1,776increase
(+176.77%)		 Filing
2020-06-09
4:33 pm
Sale		 2020-05-31 13G Evofem Biosciences, Inc.
EVFM		 BlackRock Inc.
BLK		 1,005
3.000%		 -3,230decrease
(-76.27%)		 Filing